SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : NVID International

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: P.S.N. who wrote (2674)9/2/1998 12:26:00 PM
From: KGoodson  Read Replies (2) of 3244
 
Suggest you read closely....

NVID International, Inc. Finalizes North American Ionization Distribution Rights

Business Wire - September 02, 1998 11:23
%NVID-INTL NVID %FLORIDA %BIOTECHNOLOGY %ENMED %ENVIRONMENT %CHEMICALS %PLASTICS V%BW P%BW

CLEARWATER, Fla.--(BUSINESS WIRE)--Sept. 2, 1998--NVID International, Inc. (OTCBB:NVID) announced Wednesday that it has finalized a formal agreement with EHPC Ltd. of London, England. This agreement provides NVID the manufacturing and distribution rights to a new generation of ionization equipment in North America.

The system known as the Random Metering System (RMS) delivers silver and copper ions utilizing proprietary electrode technology as a method of water disinfection. RMS is designed to be a cost effective alternative to halogens (chlorine) for disinfecting large volumes of water in either a single pass or re-circulation type water systems. The ions are metered into the process water by dosing pumps based upon flow rates which insures a controlled dosage of ions in parts per billion or parts per million of concentrate.

David Larson, President of NVID International, Inc. stated, "The RMS ionization technology differs from conventional ionization technology because the system has the ability to treat large volumes of water where controlled ion levels are critical."

Installation sites for this technology in England include Heathrow Airport (Queens Building) where all of the incoming water mains are treated to remove the bio-film from the piping distribution system for control of water-borne pathogens, including Legionella. Kew Gardens, an internationally known botanical center, employs 10 ionization units in the watering system to eliminate bio-film and control pythium, algae, fungi and Legionella. The RMS technology treats all of the incoming water mains for bio-film removal and Legionella control at Charing Cross Hospital, Royal Free Hospital and The Royal National Orthopedic Hospital Trust in London.

Potential markets for the technology include agriculture, horticulture, municipal drinking water, residential/commercial point-of-entry and point-of-use drinking water systems, reverse osmosis systems, municipal sewage effluent, cooling towers, hospitals, pools/spas and decorative fountains.

This press release contains certain forward-looking statements with respect to the future activities of the company. NVID is exploring potential corporate alliances in order to provide financial and operational resources necessary to exploit this opportunity. NVID International, Inc. and Aqua Bio Technologies, Inc. can be reached by e-mail at: aquasave@aquabiotech.com or aquabiotech@home.com

CONTACT: NVID International, Inc.
Corporate Office
(813) 669-5005 Phone, (813) 669-4701 Fax
Sales Office
(941) 312-9100 Phone, (941) 312-9300 Fax


Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext